<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>TGaceAllStories</title><link>http://example.com/interleaved_feed.xml</link><description>This is a randomly ordered feed of the most recent entries from TGaceAllStories, skipping any feeds with errors.</description><lastBuildDate>Wed, 22 Oct 2025 07:01:48 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>One theory on why gold suffered its biggest one-day fall in more than ten years</title><link>https://www.marketwatch.com/story/one-theory-on-why-gold-suffered-its-biggest-one-day-fall-in-more-than-ten-years-1ece9762?mod=mw_rss_topstories</link><image_url>https://images.mktw.net/im-45921657</image_url><description>Robin Brooks, senior fellow at the Brookings Institution, sought to explain the flows driving the price of gold</description><pubDate>Wed, 22 Oct 2025 11:23:00 GMT</pubDate></item><item><title>‘Murdaugh: Death in the Family’ star Jason Clarke sells L.A. home at big discount for $3 million</title><link>https://www.marketwatch.com/story/murdaugh-death-in-the-family-star-jason-clarke-sells-l-a-home-at-big-discount-for-3-million-88ab013f?mod=mw_rss_topstories</link><image_url>https://images.mktw.net/im-60990077</image_url><description>Jason Clarke has finally offloaded his Los Angeles home after it spent more than a year on the market and underwent several markdowns.</description><pubDate>Wed, 22 Oct 2025 10:04:00 GMT</pubDate></item><item><title>Why David Einhorn’s Greenlight prefers this tiny biotech over AI ‘excitement’</title><link>https://www.marketwatch.com/story/why-david-einhorns-greenlight-prefers-this-tiny-biotech-over-ai-excitement-df60d93f?mod=mw_rss_topstories</link><image_url>https://images.mktw.net/im-93348183</image_url><description>Greenlight Capital’s third-quarter investor letter had almost nothing good to say about the hot AI trend, but it does have faith in a tiny biotech.</description><pubDate>Wed, 22 Oct 2025 11:48:00 GMT</pubDate></item><item><title>‘I’m in the home stretch’: I’m 80. Do I leave my kids a ‘Magnificent Seven’ dynasty trust or a brokerage account?</title><link>https://www.marketwatch.com/story/im-in-the-home-stretch-im-80-do-i-leave-my-kids-a-magnificent-seven-dynasty-trust-or-a-brokerage-account-dc45c172?mod=mw_rss_topstories</link><image_url>https://images.mktw.net/im-54471438</image_url><description>“Do I leave them to pay capital-gains tax on the dynasty trust or estate tax on my personal account?”</description><pubDate>Wed, 22 Oct 2025 10:30:00 GMT</pubDate></item><item><title>The Labor Department is set to release September inflation data. October will be a real challenge.</title><link>https://www.marketwatch.com/story/the-labor-department-is-set-to-release-september-inflation-data-october-will-be-a-real-challenge-0c80b0ea?mod=mw_rss_topstories</link><image_url>https://images.mktw.net/im-27500250</image_url><description>The longer the U.S. government shutdown, the trickier it will get for the Labor Department to publish key reports, even were it to get White House app...</description><pubDate>Wed, 22 Oct 2025 10:43:00 GMT</pubDate></item><item><title>Investor Lauren Taylor Wolfe says we are 'absolutely' in an AI bubble now</title><link>https://www.cnbc.com/2025/10/21/investor-lauren-taylor-wolfe-says-we-are-absolutely-in-an-ai-bubble-now.html</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png</image_url><description>Lauren Taylor Wolfe, co-founder of Impactive Capital, said the surge in enthusiasm around artificial intelligence has all the markings of a bubble.</description><pubDate>Tue, 21 Oct 2025 18:50:08 GMT</pubDate></item><item><title>BranchOut Food’s Record Q3 Blast-Off: Shares Surge 35% on Path to Profitability – Is This Healthy Snack Play Ripe for More Gains?</title><link>https://ragingbull.com/editorial/branchout-foods-record-q3-blast-off-shares-surge-35-on-path-to-profitability-is-this-healthy-snack-play-ripe-for-more-gains/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture4.png</image_url><description>Listen, folks, if you’re glued to the markets like I am, you know those days when a stock just explodes out of nowhere? That’s exactly what’s happenin...</description><pubDate>Tue, 21 Oct 2025 16:54:43 GMT</pubDate></item><item><title>VSee Health’s Monster Teleradiology Deal Just Dropped – Is This the Telehealth Rocket Fuel Investors Have Been Craving?</title><link>https://ragingbull.com/editorial/vsee-healths-monster-teleradiology-deal-just-dropped-is-this-the-telehealth-rocket-fuel-investors-have-been-craving/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture4.png</image_url><description>Hey folks, if you’re glued to the markets like I am, you know those days when a stock just explodes out of nowhere? Well, buckle up, because as of thi...</description><pubDate>Tue, 21 Oct 2025 16:53:49 GMT</pubDate></item><item><title>Gold is getting knocked on Tuesday – it’s still the hottest trade of the year</title><link>https://www.cnbc.com/2025/10/21/gold-is-getting-knocked-on-tuesday-its-still-the-hottest-trade-of-the-year-.html</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png</image_url><description>There's another corner of the market that Wall Street is enthusiastic about.</description><pubDate>Tue, 21 Oct 2025 18:10:53 GMT</pubDate></item><item><title>Minerva Neurosciences Stock Explodes 276% on Massive $200 Million Funding Boost for Game-Changing Schizophrenia Treatment</title><link>https://ragingbull.com/editorial/minerva-neurosciences-stock-explodes-276-on-massive-200-million-funding-boost-for-game-changing-schizophrenia-treatment/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture2.png</image_url><description>Folks, if you’re glued to the markets like I am, you’ve probably seen the fireworks today. Minerva Neurosciences (NERV), a biotech player laser-focuse...</description><pubDate>Tue, 21 Oct 2025 16:52:46 GMT</pubDate></item><item><title>Morgan Stanley's top picks for the rest of earnings season</title><link>https://www.cnbc.com/2025/10/21/-morgan-stanleys-top-picks-for-the-rest-of-earnings-season.html</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png</image_url><description>These stocks are likely to appreciate as the third-quarter earnings season ramps up, according to Morgan Stanley.</description><pubDate>Tue, 21 Oct 2025 19:49:47 GMT</pubDate></item><item><title>Goldman Sachs highlights 'buyback aristocrats' in hunt for future outperformers</title><link>https://www.cnbc.com/2025/10/21/goldman-sachs-says-these-buyback-aristocrats-have-outperformed.html</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture3.png</image_url><description>An equal-weight portfolio of so-called buyback aristocrats has outperformed the equal-weight S&amp;P 500 so far this year, Goldman says. Here are names on...</description><pubDate>Tue, 21 Oct 2025 20:57:10 GMT</pubDate></item><item><title>Palantir has been sitting out this latest leg of the bull run. What the charts say happen next</title><link>https://www.cnbc.com/2025/10/21/palantir-has-been-sitting-out-this-latest-leg-of-the-bull-run-what-the-charts-say-happen-next.html</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture8.png</image_url><description>Palantir has been eerily quiet since the August sell-off.</description><pubDate>Tue, 21 Oct 2025 19:17:04 GMT</pubDate></item><item><title>Alto Neuroscience Stock Rockets Nearly 80% on Game-Changing FDA Nod for Depression Treatment Push</title><link>https://ragingbull.com/editorial/alto-neuroscience-stock-rockets-nearly-80-on-game-changing-fda-nod-for-depression-treatment-push/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture10.png</image_url><description>Hey, folks, buckle up because the market’s throwing us a curveball today that’s got biotech investors buzzing like crazy. As of this writing, shares o...</description><pubDate>Mon, 20 Oct 2025 16:33:14 GMT</pubDate></item><item><title>REPL Stock Skyrockets Over 100% as FDA Accepts Key Resubmission for Game-Changing Melanoma Therapy</title><link>https://ragingbull.com/editorial/repl-stock-skyrockets-over-100-as-fda-accepts-key-resubmission-for-game-changing-melanoma-therapy/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture8.png</image_url><description>Folks, buckle up because the market’s throwing a curveball that’s got biotech investors buzzing like never before. As of this writing, early in the tr...</description><pubDate>Mon, 20 Oct 2025 16:34:29 GMT</pubDate></item></channel></rss>